Cells

Sequencing test measured DNA caps more consistently in human blood

A measure of variation between runs was about 1.4% with sequencing versus 4.6% with the reference test for measuring telomeres, the caps at chromosome ends.

Our read

Biomarkers
Studied:
Cohort study of healthy controls and patients, against Flow-FISH
What changed:
Inter-assay variability was lower with Telo-Seq than Flow-FISH: CV ~1.4% vs. ~4.6%
Why it’s aging research:
It builds or tests a tool for aging research.

Editor of record: Boris Djordjevic · AgingResearch.News

Follow @agingbrief

In an Australian observational study, researchers assessed blood immune cells from 156 healthy adults aged 18–78 and 24 people undergoing evaluation for interstitial lung disease, a group of lung disorders. Patients included 21 with pulmonary fibrosis, or lung scarring, and three with silicosis, a disease caused by silica dust. The pulmonary fibrosis subgroup averaged 64.6 years of age and was 85.7% male. Comparisons between tests included 22 patients.

The sequencing test, Telo-Seq, read long stretches of DNA to measure telomeres. Its blood-cell results correlated with those from the clinical reference method and varied less between runs. The tests largely agreed on classifying telomeres as short relative to age-adjusted thresholds. However, some classifications differed in either direction near those thresholds. Exploratory tests also measured telomeres in lung-wash fluid and lung tissue removed during transplantation.

Why it matters

Telomere length is an age-linked feature used in evaluating lung scarring and suspected telomere disorders. The authors said the findings supported further evaluation of sequencing in disease-relevant tissues.

Caveats

The age-adjusted thresholds served as comparison tools, not definitive diagnostic cutoffs. The patient cohort was small, and the reference test’s between-run variability estimate came from one donor.

Comments

Be the first to comment.